Related Experiment Video
Updated: May 26, 2026

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
Published on: January 7, 2019
Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD
Gabriela Spulber1, Eini Niskanen, Stuart Macdonald
1University of Eastern Finland, Kuopio Campus, Institute of Clinical Medicine/Neurology, Kuopio. gabriela.spulber@uef.fi
Abstract:
Mild cognitive impairment (MCI) often represents a prodromal form of dementia, conferring a significantly higher risk of converting to probable Alzheimer's disease (AD). The aim of this study is to characterise the differences of grey matter (GM) distribution and dynamics between progressive and stable MCI subjects during a 2 year period preceding the conversion to AD. We included 48 stable MCI and 12 progressive MCI cases based on the availability of 3 serial scans acquired with approximately 1 year scan interval. For the progressive MCI group, the third scan was acquired at the time of the clinical diagnosis of AD, while the first two scans were acquired approximately 2 and 1 years earlier. For the stable MCI group, the three scans were acquired at approximately 1 year intervals during a period free from significant cognitive decline. We used longitudinal voxel-based morphometry (VBM) for mapping the progression of GM loss over time. For the progressive MCI group, the cross-sectional analysis revealed areas of lower GM volumes in the parahippocampal gyrus, precuneus and posterior cingulate 12 months before the AD diagnosis. For the longitudinal VBM analysis the progressive MCI group revealed increased GM loss in cortical regions belonging to the temporal neocortex, parahippocampal cortex, and cingulate gyrus. The frontal lobe, insula and the cerebellum were also affected. This accelerated atrophy may offer new insights into the understanding of neurodegenerative pathology and the clinical relevance of these changes remains to be verified by subsequent studies.
Insights
Progressive mild cognitive impairment (MCI) shows accelerated grey matter loss in key brain regions up to two years before Alzheimer's disease (AD) diagnosis. Stable MCI patients did not exhibit this significant brain atrophy, highlighting differences in neurodegeneration.
Area of Science:
- Neuroimaging
- Neurodegeneration
- Cognitive Neurology
Background:
- Mild cognitive impairment (MCI) is a prodromal stage for dementia, particularly Alzheimer's disease (AD).
- Understanding the neuroanatomical differences between progressive and stable MCI is crucial for early detection and intervention.
- Grey matter (GM) changes precede clinical diagnosis in neurodegenerative diseases.
Purpose of the Study:
- To characterize grey matter (GM) distribution and dynamics in progressive versus stable MCI over a two-year period before Alzheimer's disease (AD) conversion.
- To identify specific brain regions affected by GM loss in individuals who progress from MCI to AD.
Main Methods:
- Longitudinal voxel-based morphometry (VBM) analysis of three serial MRI scans.
- Inclusion of 48 stable MCI and 12 progressive MCI cases.
- Scans acquired at approximately 1-year intervals, with the final scan for the progressive group at AD diagnosis.
Main Results:
- Cross-sectional analysis revealed lower GM volumes in the parahippocampal gyrus, precuneus, and posterior cingulate 12 months before AD diagnosis in the progressive MCI group.
- Longitudinal VBM showed accelerated GM loss in temporal neocortex, parahippocampal cortex, and cingulate gyrus in progressive MCI.
- Affected regions also included the frontal lobe, insula, and cerebellum in the progressive MCI group.
Conclusions:
- Progressive MCI exhibits significant grey matter atrophy in specific cortical and subcortical regions preceding clinical Alzheimer's disease diagnosis.
- These findings offer insights into the neurodegenerative processes underlying MCI progression to AD.
- Further studies are needed to verify the clinical relevance of these observed neuroanatomical changes.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Dementia l: Introduction

